United States Biotechnology & Medical Research

Invitae Corp (NVTA)

Track

Ticker: NVTA Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Invitae Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Proposed sale 3 Jul 2023
Value US$3,902,401.86 | Price 334.23 | Shares 46,957
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-07-03 2023-07-03 PrS Proposed sale
2.3
WERNER ROBERT F.

Officer

Officer
46,957
334.23
US$3,902,402 		46,957 334.23 US$3,902,402
2023-06-15 2023-06-13 S Sale
Brida Thomas

See Remarks

Officer
39,021 -15.7%
289.39
US$2,401,981 		39,021 -15.7% 289.39 US$2,401,981
2023-06-15 2023-06-13 S Sale
Nussbaum Robert L

Chief Medical Officer

Officer
2,593 -10.6%
414.21
US$253,439 		2,593 -10.6% 414.21 US$253,439
2023-05-18 2023-05-16 S Sale
Wen Yafei

Chief Financial Officer

Officer
43,452 -5.8%
1.99
US$86,600 		43,452 -5.8% 1.99 US$86,600
2023-05-18 2023-05-16 PlS Planned sale
2.3
WERNER ROBERT F.

Chief Accounting Officer

Officer
21,559 -5.7%
1.20
US$25,856 		21,559 -5.7% 1.20 US$25,856
2023-05-18 2023-05-16 S Sale
Knight Kenneth D.

Chief Executive Officer

Executive Director
45,432 -2.6%
1.20
US$54,487 		45,432 -2.6% 1.20 US$54,487
2023-05-18 2023-05-16 S Sale
Nussbaum Robert L

Chief Medical Officer

Officer
26,476 -4.4%
1.20
US$31,753 		26,476 -4.4% 1.20 US$31,753
2023-05-18 2023-05-16 S Sale
Brida Thomas

See Remarks

Officer
26,476 -3.6%
1.20
US$31,753 		26,476 -3.6% 1.20 US$31,753
2023-03-15 2023-03-13 S Sale
Brida Thomas

See Remarks

Officer
2,625 -0.6%
1.41
US$3,701 		2,625 -0.6% 1.41 US$3,701
2023-03-15 2023-03-13 S Sale
Nussbaum Robert L

Chief Medical Officer

Officer
2,625 -0.6%
1.41
US$3,701 		2,625 -0.6% 1.41 US$3,701
2023-03-15 2023-03-13 S Sale
Knight Kenneth D.

Chief Executive Officer

Executive Director
1,853 -0.4%
1.41
US$2,613 		1,853 -0.4% 1.41 US$2,613
2023-03-15 2023-03-13 S Sale
Wen Yafei

Chief Financial Officer

Officer
2,625 -0.6%
1.41
US$3,701 		2,625 -0.6% 1.41 US$3,701
2022-12-20 2022-12-19 S Sale
3.7
George Sean E
Non-Executive Director
11,163 -1.5%
2.08
US$23,210 		11,163 -1.5% 2.08 US$23,210
2022-12-20 2022-12-16 S Sale
3.7
George Sean E
Non-Executive Director
44,816 -5.7%
2.04
US$91,420 		44,816 -5.7% 2.04 US$91,420
2022-08-29 2022-08-25 PlS Planned sale
2.3
WERNER ROBERT F.

Chief Accounting Officer

Officer
1,350 -0.5%
3.45
US$4,658 		1,350 -0.5% 3.45 US$4,658
2022-08-18 2022-08-16 S Sale
3.7
George Sean E
Non-Executive Director
22,085 -2.7%
4.55
US$100,493 		22,085 -2.7% 4.55 US$100,493
2022-08-18 2022-08-16 S Sale
2.3
WERNER ROBERT F.

Chief Accounting Officer

Officer
3,252 -1.6%
4.55
US$14,798 		3,252 -1.6% 4.55 US$14,798
2022-08-18 2022-08-16 S Sale
Brida Thomas

See remarks

Officer
7,048 -1.8%
4.55
US$32,071 		7,048 -1.8% 4.55 US$32,071
2022-08-18 2022-08-16 S Sale
Nussbaum Robert L

Chief Medical Officer

Officer
7,048 -1.7%
4.55
US$32,071 		7,048 -1.7% 4.55 US$32,071
2022-05-19 2022-05-19 PlS Planned sale
2.3
WERNER ROBERT F.

Chief Accounting Officer

Officer
2,746 -1.3%
3.40
US$9,336 		2,746 -1.3% 3.40 US$9,336
2022-05-19 2022-05-17 S Sale
Nussbaum Robert L

Chief Medical Officer

Officer
6,098 -1.5%
3.81
US$23,234 		6,098 -1.5% 3.81 US$23,234
2022-05-19 2022-05-17 S Sale
3.7
George Sean E

President & CEO

Executive Director
18,296 -2.3%
3.81
US$69,710 		18,296 -2.3% 3.81 US$69,710
2022-05-19 2022-05-17 PlS Planned sale
Brida Thomas

See Remarks

Officer
6,098 -1.5%
3.81
US$23,234 		6,098 -1.5% 3.81 US$23,234
2022-05-19 2022-05-17 S Sale
Knight Kenneth D.

Chief Operating Officer

Officer
28,295 -5.2%
3.81
US$107,807 		28,295 -5.2% 3.81 US$107,807
2022-05-19 2022-05-17 S Sale
Wen Yafei

Chief Financial Officer

Officer
17,042 -4.7%
3.81
US$64,932 		17,042 -4.7% 3.81 US$64,932
2022-05-19 2022-05-17 PlS Planned sale
2.3
WERNER ROBERT F.

Chief Accounting Officer

Officer
7,356 -3.5%
3.81
US$28,027 		7,356 -3.5% 3.81 US$28,027
2022-03-21 2022-03-14 S Sale
Knight Kenneth D.

Chief Operating Officer

Officer
2,358 -0.7%
6.69
US$15,767 		2,358 -0.7% 6.69 US$15,767
2022-03-16 2022-03-14 S Sale
Wen Yafei

Chief Financial Officer

Officer
3,289 -2.4%
6.69
US$21,992 		3,289 -2.4% 6.69 US$21,992
2022-03-16 2022-03-14 PlS Planned sale
Brida Thomas

General Counsel

Officer
17,987 -7.3%
6.69
US$120,286 		17,987 -7.3% 6.69 US$120,286
2022-03-16 2022-03-14 S Sale
Nussbaum Robert L

Chief Medical Officer

Officer
19,588 -7.5%
6.69
US$130,993 		19,588 -7.5% 6.69 US$130,993
2022-03-16 2022-03-14 S Sale
3.7
George Sean E

President & CEO

Executive Director
31,389 -3.7%
6.69
US$209,886 		31,389 -3.7% 6.69 US$209,886
2021-11-15 2021-11-11 PlS Planned sale
Nussbaum Robert L

Chief Medical Officer

Officer
29,675 -10.8%
21.89
US$649,568 		29,675 -10.8% 21.89 US$649,568
2021-10-26 2021-10-22 PlS Planned sale
3.7
George Sean E

President & CEO

Executive Director
3,675 -0.5%
28.06
US$103,120 		3,675 -0.5% 28.06 US$103,120
2021-07-23 2021-07-22 S Sale
3.7
George Sean E

President & CEO

Executive Director
3,675 -0.5%
29.39
US$108,008 		3,675 -0.5% 29.39 US$108,008
2021-06-17 2021-06-15 S Sale
Knight Kenneth D.

Chief Operating Officer

Officer
14,874 -4.6%
30.30
US$450,687 		14,874 -4.6% 30.30 US$450,687
2021-06-16 2021-06-14 S Sale
Nussbaum Robert L

Chief Medical Officer

Officer
9,910 -3.6%
31.63
US$313,405 		9,910 -3.6% 31.63 US$313,405
2021-06-16 2021-06-14 PlS Planned sale
Brida Thomas

General Counsel

Officer
9,910 -3.9%
31.63
US$313,405 		9,910 -3.9% 31.63 US$313,405
2021-06-16 2021-06-14 S Sale
Guyer Shelly D

Chief Financial Officer

Officer
9,910 -3.9%
31.63
US$313,405 		9,910 -3.9% 31.63 US$313,405
2021-06-16 2021-06-14 S Sale
2.3
Stueland Katherine

Chief Commercial Officer

Officer
8,834 -4.0%
31.63
US$279,376 		8,834 -4.0% 31.63 US$279,376
2021-06-16 2021-06-14 PlS Planned sale
2.3
Stueland Katherine

Chief Commercial Officer

Officer
11,506 -4.9%
31.58
US$363,303 		11,506 -4.9% 31.58 US$363,303
2021-05-24 2021-05-20 S Sale
3.7
George Sean E

President & CEO

Executive Director
3,675 -0.5%
28.00
US$102,900 		3,675 -0.5% 28.00 US$102,900
2021-05-20 2021-05-18 S Sale
2.3
WERNER ROBERT F.

Chief Accounting Officer

Officer
3,576
0.00
US$0 		3,576 0.00 US$0
2021-05-20 2021-05-18 S Sale
2.3
WERNER ROBERT F.

Chief Accounting Officer

Officer
1,000
0.00
US$0 		1,000 0.00 US$0
2021-05-20 2021-05-18 S Sale
2.3
WERNER ROBERT F.

Chief Accounting Officer

Officer
1,469
0.00
US$0 		1,469 0.00 US$0
2021-05-20 2021-05-18 S Sale
2.3
WERNER ROBERT F.

Chief Accounting Officer

Officer
262
0.00
US$0 		262 0.00 US$0
2021-05-20 2021-05-18 S Sale
2.3
WERNER ROBERT F.

Chief Accounting Officer

Officer
346
0.00
US$0 		346 0.00 US$0
2021-04-15 2021-04-14 PlS Planned sale
2.3
Stueland Katherine

Chief Commercial Officer

Officer
100 -0.1%
41.02
US$4,102 		100 -0.1% 41.02 US$4,102
2021-04-15 2021-04-14 PlS Planned sale
2.3
Stueland Katherine

Chief Commercial Officer

Officer
9,799 -4.9%
40.37
US$395,581 		9,799 -4.9% 40.37 US$395,581
2021-04-15 2021-04-14 PlS Planned sale
2.3
Stueland Katherine

Chief Commercial Officer

Officer
9,994 -4.8%
39.38
US$393,527 		9,994 -4.8% 39.38 US$393,527
2021-03-23 2021-03-22 PlS Planned sale
3.7
George Sean E

President & CEO

Executive Director
601 -0.1%
43.51
US$26,148 		601 -0.1% 43.51 US$26,148
2021-03-23 2021-03-22 PlS Planned sale
3.7
George Sean E

President & CEO

Executive Director
1,825 -0.3%
42.89
US$78,276 		1,825 -0.3% 42.89 US$78,276
2021-03-23 2021-03-22 PlS Planned sale
3.7
George Sean E

President & CEO

Executive Director
1,249 -0.2%
41.77
US$52,172 		1,249 -0.2% 41.77 US$52,172
2021-03-17 2021-03-15 S Sale
3.7
George Sean E

President & CEO

Executive Director
13,425 -1.9%
42.90
US$575,941 		13,425 -1.9% 42.90 US$575,941
2021-03-17 2021-03-15 S Sale
3.7
George Sean E

President & CEO

Executive Director
13,992 -2.0%
42.90
US$600,265 		13,992 -2.0% 42.90 US$600,265
2021-03-17 2021-03-15 S Sale
Guyer Shelly D

Chief Financial Officer

Officer
6,265 -2.7%
42.90
US$268,772 		6,265 -2.7% 42.90 US$268,772
2021-03-17 2021-03-15 S Sale
Guyer Shelly D

Chief Financial Officer

Officer
11,882 -4.8%
42.90
US$509,745 		11,882 -4.8% 42.90 US$509,745
2021-03-17 2021-03-15 S Sale
2.3
Stueland Katherine

Chief Commercial Officer

Officer
12,443 -5.5%
42.90
US$533,812 		12,443 -5.5% 42.90 US$533,812
2021-03-17 2021-03-12 S Sale
Nussbaum Robert L

Chief Medical Officer

Officer
6,265 -2.6%
42.90
US$268,772 		6,265 -2.6% 42.90 US$268,772
2021-03-17 2021-03-12 S Sale
Nussbaum Robert L

Chief Medical Officer

Officer
11,894 -4.8%
42.90
US$510,260 		11,894 -4.8% 42.90 US$510,260
2021-03-17 2021-03-12 S Sale
Brida Thomas

General Counsel

Officer
6,265 -2.9%
42.90
US$268,772 		6,265 -2.9% 42.90 US$268,772
2021-03-17 2021-03-12 S Sale
Brida Thomas

General Counsel

Officer
9,786 -4.3%
42.90
US$419,825 		9,786 -4.3% 42.90 US$419,825
2021-03-05 2021-03-04 PlS Planned sale
3.7
George Sean E

President & CEO

Executive Director
100 -0.0%
39.16
US$3,916 		100 -0.0% 39.16 US$3,916
2021-03-05 2021-03-04 PlS Planned sale
3.7
George Sean E

President & CEO

Executive Director
300 -0.0%
38.09
US$11,427 		300 -0.0% 38.09 US$11,427
2021-03-05 2021-03-04 PlS Planned sale
3.7
George Sean E

President & CEO

Executive Director
1,200 -0.2%
37.24
US$44,684 		1,200 -0.2% 37.24 US$44,684
2021-03-05 2021-03-04 PlS Planned sale
3.7
George Sean E

President & CEO

Executive Director
2,075 -0.3%
36.01
US$74,724 		2,075 -0.3% 36.01 US$74,724
2021-03-03 2021-03-02 PlS Planned sale
Guyer Shelly D

Chief Financial Officer

Officer
300 -0.1%
44.17
US$13,250 		300 -0.1% 44.17 US$13,250
2021-03-03 2021-03-02 PlS Planned sale
Guyer Shelly D

Chief Financial Officer

Officer
1,100 -0.5%
43.34
US$47,672 		1,100 -0.5% 43.34 US$47,672
2021-03-03 2021-03-02 PlS Planned sale
Guyer Shelly D

Chief Financial Officer

Officer
1,600 -0.7%
42.50
US$68,003 		1,600 -0.7% 42.50 US$68,003
2021-03-03 2021-03-01 PlS Planned sale
Brida Thomas

General Counsel

Officer
3,319 -1.6%
43.96
US$145,894 		3,319 -1.6% 43.96 US$145,894
2021-03-03 2021-03-01 PlS Planned sale
Brida Thomas

General Counsel

Officer
1,481 -0.7%
43.35
US$64,196 		1,481 -0.7% 43.35 US$64,196
2021-03-03 2021-03-01 PlS Planned sale
Brida Thomas

General Counsel

Officer
200 -0.1%
41.50
US$8,300 		200 -0.1% 41.50 US$8,300
2021-02-26 2021-02-25 PlS Planned sale
2.3
Stueland Katherine

Chief Commercial Officer

Officer
300 -0.1%
41.75
US$12,524 		300 -0.1% 41.75 US$12,524
2021-02-26 2021-02-25 PlS Planned sale
2.3
Stueland Katherine

Chief Commercial Officer

Officer
1,300 -0.6%
40.97
US$53,260 		1,300 -0.6% 40.97 US$53,260
2021-02-26 2021-02-25 PlS Planned sale
2.3
Stueland Katherine

Chief Commercial Officer

Officer
2,300 -1.1%
39.65
US$91,196 		2,300 -1.1% 39.65 US$91,196
2021-02-26 2021-02-25 PlS Planned sale
2.3
Stueland Katherine

Chief Commercial Officer

Officer
1,100 -0.5%
38.95
US$42,844 		1,100 -0.5% 38.95 US$42,844
Explore more

More insider trading research around Invitae Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America